Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
March
Session III: Current Challenges in Colorectal Cancer
Debate: First-Line Treatment in Left-Sided, RAS/BRAF Wild-Type Metastatic Colorectal Cancer: EGFR Inhibitors vs. VEGF Inhibitors - VEGF
Friday, March 25, 2022
1:58 PM – 2:06 PM
Debate Speaker(s)
Cathy Eng, MD, FACP, FASCO
Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center